KALYSIA ZIMMERMAN: Open Payments
NPI 1912427121 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$540 in 20 payments from 9 companies in 2025. Trend: 2023 $92 · 2024 $147 · 2025 $540
Food & beverage: $404Education: $136
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 4 | $170 |
| Astellas Pharma US Inc | 3 | $132 |
| Janssen Biotech, Inc. | 5 | $93 |
| Sumitomo Pharma America, Inc. | 2 | $34 |
| ABBVIE INC. | 2 | $31 |
| PFIZER INC. | 1 | $27 |
| Boston Scientific Corporation | 1 | $20 |
| Olympus America Inc. | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: INTERSTIM, ERLEADA, Xtandi, GEMTESA, Axonics, iTIND System, BOTOX, Nubeqa.
Industry payments across MI — which companies pay providers there.
